{"gene":"GSTM1","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1985,"finding":"GSTM1 (class-mu glutathione transferase) was identified as a distinct enzyme class based on amino-terminal amino acid sequences, substrate specificities, inhibitor sensitivities, and immunological cross-reactivity, establishing the alpha, mu, and pi classification of cytosolic glutathione transferases across rat, mouse, and human species.","method":"Amino-terminal sequencing, substrate specificity assays, inhibitor sensitivity panels, immunoprecipitation with class-specific antibodies, pattern recognition analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — multi-method biochemical characterization across species, foundational classification paper with >1000 citations","pmids":["3864155"],"is_preprint":false},{"year":1988,"finding":"The GSTM1-null phenotype (absence of class-mu glutathione transferase activity on trans-stilbene oxide) results from a gene deletion: individuals lacking enzyme activity also lack class-mu GT mRNA and a corresponding genomic restriction fragment, demonstrating that homozygous gene deletion abolishes GSTM1 expression.","method":"Northern blotting for mRNA levels, Southern blotting of genomic DNA with class-mu cDNA probe, enzyme activity assays in peripheral leukocytes","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — reconstitution of genotype-phenotype link with mRNA, genomic DNA, and enzymatic activity, >600 citations","pmids":["3174634"],"is_preprint":false},{"year":1993,"finding":"GSTM1, GSTM2, GSTM3, GSTM4, and GSTM5 were mapped to human chromosome 1p13.3 as a tandem gene cluster spanning ~100 kb; the close physical proximity of GSTM1 and GSTM2 (99% nucleotide sequence identity in 3'-UTR) suggests the GSTM1-null allele arises from unequal crossing-over.","method":"Locus-specific PCR on human/hamster somatic cell hybrid DNAs, Southern blot hybridization, fluorescence in situ hybridization (FISH) with a yeast artificial chromosome clone containing all five genes","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal mapping methods, replicated across somatic cell hybrids and FISH","pmids":["8317488"],"is_preprint":false},{"year":2001,"finding":"Mouse GSTM1-1 (mGSTM1-1) physically interacts with apoptosis signal-regulating kinase 1 (ASK1), suppresses ASK1 kinase activity and oligomerization, and inhibits ASK1-dependent apoptosis; binding requires the C-terminal portion of mGSTM1-1 and the N-terminal region of ASK1, and this inhibitory function is independent of GSTM1's glutathione-conjugating catalytic activity.","method":"Yeast two-hybrid screen for ASK1-interacting proteins; co-immunoprecipitation in vivo and in vitro binding assay confirming direct interaction; domain-mapping with deletion constructs; kinase activity assay in cultured cells; ASK1 oligomerization assay; apoptosis assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — yeast two-hybrid plus reciprocal Co-IP plus in vitro binding plus functional kinase/apoptosis assays, >300 citations","pmids":["11278289"],"is_preprint":false},{"year":2001,"finding":"Human cell lines expressing functional GSTM1 are significantly more resistant to styrene-7,8-oxide (SO)-induced cytotoxicity and mutagenicity at the HPRT locus than GSTM1-null cell lines, directly demonstrating that GSTM1 enzymatic activity conjugates SO and reduces its genotoxic hazard.","method":"RT-PCR and immunochemistry for GSTM1 status in human cell lines; dose-response cytotoxicity assay; HPRT mutation frequency assay with 6-thioguanine selection","journal":"Environmental and molecular mutagenesis","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal cell-based assays in isogenic GSTM1-present vs. null lines, single study","pmids":["11424177"],"is_preprint":false},{"year":2004,"finding":"GSTM1 null genotype (loss of GSTM1 enzyme activity) results in significantly higher micronucleus frequency in human lymphocytes treated with hydroquinone compared to GSTM1-present individuals, establishing GSTM1's role in detoxifying hydroquinone and protecting against genotoxic DNA damage.","method":"GSTM1 genotyping of 15 healthy donors; ex vivo lymphocyte culture treatment with hydroquinone; cytokinesis-block micronucleus assay; sister-chromatid exchange assay","journal":"Environmental and molecular mutagenesis","confidence":"Medium","confidence_rationale":"Tier 2 — direct functional comparison in human cells stratified by GSTM1 genotype, single study","pmids":["15141365"],"is_preprint":false},{"year":2004,"finding":"GSTM1 null genotype modifies the adjuvant effect of diesel exhaust particles on nasal allergic responses: GSTM1-null individuals show significantly greater IgE and histamine increases after diesel exhaust particle plus allergen challenge compared to GSTM1-functional individuals, indicating GSTM1's role in metabolizing reactive oxygen species generated by diesel exhaust particles.","method":"Randomised, placebo-controlled crossover nasal challenge study; intranasal allergen ± diesel exhaust particle challenge; nasal lavage measurement of IgE, histamine, IL-4, IFN-γ; GSTM1/GSTP1 genotyping","journal":"Lancet (London, England)","confidence":"High","confidence_rationale":"Tier 2 — randomised controlled crossover design with direct functional genotype-phenotype comparison, >200 citations","pmids":["14726165"],"is_preprint":false},{"year":2009,"finding":"A functional polymorphism in the GSTM1 promoter alters AP-2α transcription factor binding, reducing promoter activity and mRNA expression; notably, both the null (-/-) and homozygous wild-type (+/+) genotypes confer breast cancer risk relative to heterozygotes (+/-), revealing a U-shaped gene-dosage association and indicating that GSTM1 expression level critically determines its protective or detrimental role.","method":"Case-control genotyping (1920 subjects) with distinction of null/heterozygous/homozygous genotypes; meta-analysis of 41 studies; electrophoretic mobility shift assay (EMSA) for AP-2α binding to promoter variant; luciferase reporter promoter activity assay; quantitative RT-PCR for mRNA expression","journal":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","confidence":"High","confidence_rationale":"Tier 1-2 — EMSA plus reporter assay plus mRNA quantification establishing functional promoter mechanism, replicated in meta-analysis","pmids":["19228880"],"is_preprint":false},{"year":2012,"finding":"GSTM1 functions as an antioxidant enzyme regulated by the NRF2 (NF-E2-related factor 2) transcription factor pathway and acts through interactions with other genes and environmental factors (particularly air pollutants) to modulate lung inflammatory responses; GSTM1-null individuals show increased susceptibility to oxidant-driven pulmonary inflammation.","method":"Review synthesizing epidemiological, clinical, animal model, and in vitro studies; evidence from GSTM1 knockout/knockdown experiments and NRF2 pathway analyses","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 3 — review integrating multiple experimental systems; primary mechanistic evidence from cited in vitro/animal studies","pmids":["22683820"],"is_preprint":false},{"year":2019,"finding":"Hypomethylation of the GSTM1 promoter in ectopic and eutopic endometrium of patients with ovarian endometriosis correlates with higher GSTM1 mRNA and protein expression; in vitro overexpression of GSTM1 in endometrial epithelial cells increases cell viability and inhibits apoptosis following hormone treatment and withdrawal, consistent with GSTM1's known role in suppressing apoptosis-related signalling (e.g., ASK1).","method":"Pyrosequencing of GSTM1 promoter CpG methylation; RT-qPCR and immunohistochemistry for GSTM1 expression; primary endometrial epithelial cell culture; GSTM1 overexpression by gene transfection; CCK-8 viability assay; flow cytometry for apoptosis","journal":"Human reproduction (Oxford, England)","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods linking promoter methylation to expression and functional apoptosis phenotype, single study","pmids":["30989213"],"is_preprint":false},{"year":2008,"finding":"Population-specific copy number variation (CNV) of GSTM1 was identified: >75% of Caucasian (CEU) samples carry GSTM1 deletion and none have two copies, whereas up to 25% of African (YRI) samples carry two copies; an upstream deletion marker (pseudo-SNP rs366631 on HapMap) serves as an indicator of full GSTM1 gene deletion.","method":"Site-specific genotyping assays for GSTM1 and a homologous upstream region; novel GSTM1 CNV assay applied to HapMap CEU and YRI lymphoblastoid cell lines; genome-wide association analysis identifying false SNP call due to sequence homology","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 — novel CNV assay with population-specific validation, single study","pmids":["18948376"],"is_preprint":false}],"current_model":"GSTM1 encodes a class-mu cytosolic glutathione S-transferase whose primary catalytic function is conjugation of electrophilic compounds (including carcinogens such as styrene oxide and hydroquinone, and reactive oxygen species from pollutants) with glutathione to facilitate their detoxification; independently of its catalytic activity, GSTM1 protein directly binds and inhibits apoptosis signal-regulating kinase 1 (ASK1) by suppressing its oligomerization and kinase activity, thereby modulating stress-induced apoptosis; GSTM1 expression is regulated at the promoter level by AP-2α binding and by DNA methylation, and the common null allele (arising from homozygous gene deletion via unequal crossing-over at the chromosome 1p13.3 cluster) completely abolishes both enzymatic and ASK1-inhibitory functions, predisposing null individuals to increased genotoxic damage and inflammatory responses."},"narrative":{"teleology":[{"year":1985,"claim":"Identification of GSTM1 as a distinct enzyme class (mu) among cytosolic glutathione transferases established the foundational biochemical classification and substrate specificity framework for the gene family.","evidence":"Amino-terminal sequencing, substrate specificity profiling, inhibitor sensitivity panels, and immunoprecipitation across rat, mouse, and human tissues","pmids":["3864155"],"confidence":"High","gaps":["Catalytic mechanism at the active-site level not resolved","No structural model available at this point","Human isoform-specific functions not distinguished"]},{"year":1988,"claim":"Demonstration that the GSTM1-null phenotype arises from a homozygous gene deletion—abolishing mRNA expression and enzyme activity—explained the polymorphic absence of mu-class GST activity in human populations and established the null genotype as a binary loss-of-function variant.","evidence":"Northern blotting, Southern blotting with class-mu cDNA probe, and enzyme activity assays in peripheral leukocytes","pmids":["3174634"],"confidence":"High","gaps":["Precise molecular breakpoints of the deletion not mapped","Functional consequences beyond trans-stilbene oxide metabolism not yet tested"]},{"year":1993,"claim":"Mapping all five GSTM genes to a tandem cluster at 1p13.3 and identifying near-identical 3′-UTR sequences between GSTM1 and GSTM2 provided a mechanistic explanation for null-allele generation through unequal crossing-over.","evidence":"Locus-specific PCR on somatic cell hybrids, Southern blot hybridization, and FISH with a YAC clone containing the full cluster","pmids":["8317488"],"confidence":"High","gaps":["Exact recombination breakpoints not sequenced","Frequency of de novo deletion events unknown"]},{"year":2001,"claim":"Discovery that GSTM1 physically binds and inhibits ASK1—suppressing its oligomerization, kinase activity, and downstream apoptosis independently of glutathione conjugation—revealed a catalysis-independent signalling function for GSTM1.","evidence":"Yeast two-hybrid screen, reciprocal co-immunoprecipitation, in vitro binding assay, domain-deletion mapping, kinase activity assay, and apoptosis assay in cultured cells (mouse GSTM1)","pmids":["11278289"],"confidence":"High","gaps":["Structural basis of the GSTM1–ASK1 interface not determined","Relevance of ASK1 inhibition in human tissues under physiological conditions not tested","Whether other GST-mu family members share ASK1-inhibitory activity unclear"]},{"year":2001,"claim":"Functional demonstration that GSTM1-positive human cells resist styrene oxide–induced cytotoxicity and mutagenicity directly linked GSTM1 enzymatic activity to protection against an occupational carcinogen.","evidence":"Dose-response cytotoxicity and HPRT mutation frequency assays in isogenic GSTM1-present versus GSTM1-null human cell lines","pmids":["11424177"],"confidence":"Medium","gaps":["Single study; replication in additional cell types needed","In vivo dosimetry not established"]},{"year":2004,"claim":"Evidence that GSTM1-null individuals show augmented allergic inflammation (higher IgE, histamine) upon diesel exhaust particle challenge, and greater hydroquinone-induced genotoxic damage, extended GSTM1's protective role from chemical carcinogen metabolism to pollutant-driven immune modulation and environmental genotoxicity.","evidence":"Randomised crossover nasal challenge study with diesel exhaust particles (human); ex vivo micronucleus assay in GSTM1-genotyped human lymphocytes treated with hydroquinone","pmids":["14726165","15141365"],"confidence":"High","gaps":["Downstream mediators linking GSTM1-null status to enhanced IgE production not identified","Whether GSTM1 directly detoxifies diesel exhaust particle-derived ROS or acts indirectly not resolved"]},{"year":2008,"claim":"Characterization of population-specific GSTM1 copy number variation showed that >75% of Caucasians carry the deletion while African populations retain higher copy numbers, highlighting the need to account for CNV rather than simple SNP-based genotyping in association studies.","evidence":"Novel CNV genotyping assay applied to HapMap CEU and YRI lymphoblastoid cell lines","pmids":["18948376"],"confidence":"Medium","gaps":["Functional impact of carrying two versus one copy not directly measured","Broader global population survey of CNV not performed"]},{"year":2009,"claim":"Identification of a functional promoter polymorphism that alters AP-2α transcription factor binding, reducing GSTM1 transcription and revealing a U-shaped gene-dosage effect on breast cancer risk, established that GSTM1 expression level—not just presence versus absence—is a critical determinant of its biological impact.","evidence":"Case-control genotyping (1920 subjects), meta-analysis of 41 studies, EMSA for AP-2α binding, luciferase reporter assay, and quantitative RT-PCR","pmids":["19228880"],"confidence":"High","gaps":["Mechanism underlying the detrimental effect of very high GSTM1 expression not elucidated","Other transcription factors regulating GSTM1 beyond AP-2α and NRF2 not comprehensively surveyed"]},{"year":2019,"claim":"Linking GSTM1 promoter hypomethylation to elevated expression in endometriosis, and showing that GSTM1 overexpression increases cell viability and suppresses apoptosis in endometrial epithelial cells, connected the ASK1-inhibitory function to a disease-relevant phenotype and identified epigenetic regulation as a physiological control mechanism.","evidence":"Pyrosequencing of promoter CpG methylation, RT-qPCR, immunohistochemistry, GSTM1 overexpression in primary endometrial cells, CCK-8 viability assay, and flow cytometry for apoptosis","pmids":["30989213"],"confidence":"Medium","gaps":["Causal relationship between GSTM1 overexpression and endometriosis pathogenesis not established","Whether anti-apoptotic effect is mediated via ASK1 in this context not directly tested","No in vivo model used"]},{"year":null,"claim":"The structural basis of the GSTM1–ASK1 interaction, the precise mechanism by which high GSTM1 expression becomes detrimental, and the relative contributions of catalytic versus non-catalytic functions in specific disease contexts remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No co-crystal or cryo-EM structure of the GSTM1–ASK1 complex","Quantitative contribution of catalytic detoxification versus ASK1 inhibition to cancer or inflammatory protection not separated in vivo","Comprehensive identification of additional non-catalytic binding partners not performed"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,4,5]},{"term_id":"GO:0016209","term_label":"antioxidant activity","supporting_discovery_ids":[6,8]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,9]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,1]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,4,5]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[3,9]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3]},{"term_id":"R-HSA-9748784","term_label":"Drug ADME","supporting_discovery_ids":[4,5,6]}],"complexes":[],"partners":["MAP3K5"],"other_free_text":[]},"mechanistic_narrative":"GSTM1 is a class-mu cytosolic glutathione S-transferase that conjugates electrophilic substrates—including carcinogens such as styrene oxide and hydroquinone, and reactive oxygen species derived from pollutants—with glutathione, thereby protecting cells from genotoxic damage and oxidant-driven inflammation [PMID:3864155, PMID:11424177, PMID:15141365, PMID:14726165]. Independent of its catalytic activity, GSTM1 directly binds apoptosis signal-regulating kinase 1 (ASK1) through its C-terminal domain, suppressing ASK1 oligomerization and kinase activity to inhibit stress-induced apoptosis [PMID:11278289, PMID:30989213]. The common GSTM1-null allele, generated by homozygous deletion via unequal crossing-over within the tandem gene cluster at chromosome 1p13.3, eliminates both enzymatic and ASK1-inhibitory functions; GSTM1 transcription is further modulated by AP-2α binding at a functional promoter polymorphism and by promoter CpG methylation [PMID:3174634, PMID:8317488, PMID:19228880, PMID:30989213]. GSTM1-null individuals exhibit heightened susceptibility to pollutant-augmented allergic inflammation and increased genotoxic damage, consistent with loss of both detoxification and anti-apoptotic protective mechanisms [PMID:14726165, PMID:15141365]."},"prefetch_data":{"uniprot":{"accession":"P09488","full_name":"Glutathione S-transferase Mu 1","aliases":["GST HB subunit 4","GST class-mu 1","GSTM1-1","GSTM1a-1a","GSTM1b-1b","GTH4"],"length_aa":218,"mass_kda":25.7,"function":"Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Involved in the formation of glutathione conjugates of both prostaglandin A2 (PGA2) and prostaglandin J2 (PGJ2) (PubMed:9084911). Participates in the formation of novel hepoxilin regioisomers (PubMed:21046276)","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/P09488/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GSTM1","classification":"Not Classified","n_dependent_lines":4,"n_total_lines":1090,"dependency_fraction":0.003669724770642202},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GSTM1","total_profiled":1310},"omim":[{"mim_id":"620557","title":"IQ MOTIF- AND UBIQUITIN DOMAIN-CONTAINING PROTEIN; IQUB","url":"https://www.omim.org/entry/620557"},{"mim_id":"606963","title":"PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; COPD","url":"https://www.omim.org/entry/606963"},{"mim_id":"600859","title":"AMINOACYL tRNA SYNTHETASE COMPLEX-INTERACTING MULTIFUNCTIONAL PROTEIN 2; AIMP2","url":"https://www.omim.org/entry/600859"},{"mim_id":"600436","title":"GLUTATHIONE S-TRANSFERASE, THETA-1; GSTT1","url":"https://www.omim.org/entry/600436"},{"mim_id":"211980","title":"LUNG CANCER","url":"https://www.omim.org/entry/211980"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"},{"location":"Microtubules","reliability":"Additional"},{"location":"Cytokinetic bridge","reliability":"Additional"},{"location":"Primary cilium","reliability":"Additional"},{"location":"Primary cilium tip","reliability":"Additional"},{"location":"Primary cilium transition zone","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"liver","ntpm":569.8}],"url":"https://www.proteinatlas.org/search/GSTM1"},"hgnc":{"alias_symbol":["MU","H-B"],"prev_symbol":["GST1"]},"alphafold":{"accession":"P09488","domains":[{"cath_id":"3.40.30.10","chopping":"2-84","consensus_level":"medium","plddt":98.4418,"start":2,"end":84},{"cath_id":"1.20.1050.10","chopping":"90-191","consensus_level":"medium","plddt":98.3773,"start":90,"end":191}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P09488","model_url":"https://alphafold.ebi.ac.uk/files/AF-P09488-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P09488-F1-predicted_aligned_error_v6.png","plddt_mean":98.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GSTM1","jax_strain_url":"https://www.jax.org/strain/search?query=GSTM1"},"sequence":{"accession":"P09488","fasta_url":"https://rest.uniprot.org/uniprotkb/P09488.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P09488/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P09488"}},"corpus_meta":[{"pmid":"10842167","id":"PMC_10842167","title":"Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10842167","citation_count":475,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16489449","id":"PMC_16489449","title":"Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors.","date":"2006","source":"Naunyn-Schmiedeberg's archives of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16489449","citation_count":284,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8878101","id":"PMC_8878101","title":"Functional antagonism of mu-, delta- and kappa-opioid antinociception by orphanin FQ.","date":"1996","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/8878101","citation_count":205,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6094016","id":"PMC_6094016","title":"Site-specific recognition of the bacteriophage Mu ends by the Mu A protein.","date":"1984","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/6094016","citation_count":193,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8317488","id":"PMC_8317488","title":"Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13.","date":"1993","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8317488","citation_count":190,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1846441","id":"PMC_1846441","title":"Immunomodulatory activity of mu- and kappa-selective opioid agonists.","date":"1991","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1846441","citation_count":161,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8090746","id":"PMC_8090746","title":"An ethylene-responsive enhancer element is involved in the senescence-related expression of the carnation glutathione-S-transferase (GST1) gene.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8090746","citation_count":157,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2546681","id":"PMC_2546681","title":"Efficient Mu transposition requires interaction of transposase with a DNA sequence at the Mu operator: implications for regulation.","date":"1989","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/2546681","citation_count":148,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11585745","id":"PMC_11585745","title":"Polymorphisms in glutathione S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer.","date":"2001","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/11585745","citation_count":146,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3139821","id":"PMC_3139821","title":"Feedback inhibition of immunoglobulin gene rearrangement by membrane mu, but not by secreted mu heavy chains.","date":"1988","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/3139821","citation_count":134,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10739168","id":"PMC_10739168","title":"Variation in induced CYP1A1 levels: relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms.","date":"2000","source":"Pharmacogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/10739168","citation_count":126,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18270371","id":"PMC_18270371","title":"Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis.","date":"2008","source":"American journal of epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/18270371","citation_count":121,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6329690","id":"PMC_6329690","title":"Deletions in immunoglobulin mu chains.","date":"1982","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/6329690","citation_count":105,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11159742","id":"PMC_11159742","title":"GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer.","date":"2001","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/11159742","citation_count":100,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9276626","id":"PMC_9276626","title":"Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms and lung cancer risk among Northwestern Mediterraneans.","date":"1997","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/9276626","citation_count":100,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1427788","id":"PMC_1427788","title":"Detection of GST1 gene deletion by the polymerase chain reaction and its possible correlation with stomach cancer in Japanese.","date":"1992","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1427788","citation_count":99,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20183528","id":"PMC_20183528","title":"Genetic Polymorphism in Glutathione Transferases (GST): Population distribution of GSTM1, T1, and P1 conjugating activity.","date":"2009","source":"Journal of toxicology and environmental health. Part B, Critical reviews","url":"https://pubmed.ncbi.nlm.nih.gov/20183528","citation_count":99,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10493109","id":"PMC_10493109","title":"Differential binding properties of oripavines at cloned mu- and delta-opioid receptors.","date":"1999","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10493109","citation_count":95,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2015293","id":"PMC_2015293","title":"Comparison of the autolyzed and unautolyzed forms of mu- and m-calpain from bovine skeletal muscle.","date":"1991","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/2015293","citation_count":90,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10207629","id":"PMC_10207629","title":"Glutathione S-transferase-mu (GSTM1) and -theta (GSTT1) genotypes in the etiology of prostate cancer.","date":"1999","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/10207629","citation_count":89,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10753202","id":"PMC_10753202","title":"CYP1A1 and GSTM1 polymorphisms affect urinary 1-hydroxypyrene levels after PAH exposure.","date":"2000","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/10753202","citation_count":89,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33579956","id":"PMC_33579956","title":"How μ-opioid receptor recognizes fentanyl.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33579956","citation_count":86,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10383893","id":"PMC_10383893","title":"Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias.","date":"1999","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/10383893","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11368076","id":"PMC_11368076","title":"Insights into mu opioid pharmacology the role of mu opioid receptor subtypes.","date":"2001","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/11368076","citation_count":75,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12175548","id":"PMC_12175548","title":"GSTM1, GSTT1 and GSTP1 polymorphisms and lung cancer risk.","date":"2002","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/12175548","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10952100","id":"PMC_10952100","title":"Lung cancer risk in nonsmokers and GSTM1 and GSTT1 genetic polymorphism.","date":"2000","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/10952100","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"876022","id":"PMC_876022","title":"Kinetics of Mu DNA synthesis.","date":"1977","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/876022","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18398695","id":"PMC_18398695","title":"Genetic polymorphisms of GSTO2, GSTM1, and GSTT1 and risk of gastric cancer.","date":"2008","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/18398695","citation_count":70,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"4084207","id":"PMC_4084207","title":"The human glutathione S-transferases: developmental aspects of the GST1, GST2, and GST3 loci.","date":"1985","source":"Biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/4084207","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15638917","id":"PMC_15638917","title":"Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India.","date":"2005","source":"BJU international","url":"https://pubmed.ncbi.nlm.nih.gov/15638917","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11912185","id":"PMC_11912185","title":"The gene for the muted (mu) mouse, a model for Hermansky-Pudlak syndrome, defines a novel protein which regulates vesicle trafficking.","date":"2002","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11912185","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12388636","id":"PMC_12388636","title":"Synergy between mu opioid ligands: evidence for functional interactions among mu opioid receptor subtypes.","date":"2002","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/12388636","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26104374","id":"PMC_26104374","title":"Transposable Phage Mu.","date":"2014","source":"Microbiology spectrum","url":"https://pubmed.ncbi.nlm.nih.gov/26104374","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9329643","id":"PMC_9329643","title":"Influence of GSTM1 and NAT2 genotypes on placental DNA adducts in an environmentally exposed population.","date":"1997","source":"Environmental and molecular mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/9329643","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9202749","id":"PMC_9202749","title":"Polymorphisms of CYP1A1 and GSTM1 influence the in vivo function of CYP1A2.","date":"1997","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/9202749","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17461521","id":"PMC_17461521","title":"Polymorphisms of CYP1A1 and GSTM1 genes and susceptibility to oral cancer.","date":"2007","source":"Yonsei medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/17461521","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10970678","id":"PMC_10970678","title":"Involvement of central mu- but not delta- or kappa-opioid receptors in immunomodulation.","date":"2000","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/10970678","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11313824","id":"PMC_11313824","title":"Enhanced cationic liposome-mediated transfection using the DNA-binding peptide mu (mu) from the adenovirus core.","date":"2001","source":"Gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/11313824","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9150753","id":"PMC_9150753","title":"DNA adducts in human placenta as related to air pollution and to GSTM1 genotype.","date":"1997","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/9150753","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19482692","id":"PMC_19482692","title":"Regulation of mu-opioid receptors by cytokines.","date":"2009","source":"Frontiers in bioscience (Scholar edition)","url":"https://pubmed.ncbi.nlm.nih.gov/19482692","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9450617","id":"PMC_9450617","title":"Effects of mu- and kappa-opioid receptors on postoperative ileus in rats.","date":"1997","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9450617","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"159363","id":"PMC_159363","title":"Unusual modification of bacteriophage Mu DNA.","date":"1979","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/159363","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16030123","id":"PMC_16030123","title":"GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma.","date":"2005","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/16030123","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19228880","id":"PMC_19228880","title":"A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer.","date":"2009","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/19228880","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25968837","id":"PMC_25968837","title":"The mechanism of ligand-induced activation or inhibition of μ- and κ-opioid receptors.","date":"2015","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/25968837","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15579657","id":"PMC_15579657","title":"Maternal genetic polymorphisms in CYP1A1, GSTM1 and GSTT1 and the risk of hypospadias.","date":"2004","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/15579657","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1657926","id":"PMC_1657926","title":"Transposase contacts with mu DNA ends.","date":"1991","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1657926","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10817498","id":"PMC_10817498","title":"Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma.","date":"2000","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/10817498","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12150456","id":"PMC_12150456","title":"GSTM1 and GSTT1 polymorphisms and postmenopausal breast cancer risk.","date":"2002","source":"Breast cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/12150456","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7642646","id":"PMC_7642646","title":"Disassembly of the bacteriophage Mu transposase for the initiation of Mu DNA replication.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7642646","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17568619","id":"PMC_17568619","title":"Association of glutathione S-transferase gene polymorphisms (GSTM1 and GSTT1) of vitiligo in Korean population.","date":"2007","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17568619","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11173863","id":"PMC_11173863","title":"Susceptibility genes: GSTM1 and GSTM3 as genetic risk factors in bladder cancer.","date":"2000","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11173863","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17336938","id":"PMC_17336938","title":"Mu (mu) opioid receptor regulation of ethanol-induced dopamine response in the ventral striatum: evidence of genotype specific sexual dimorphic epistasis.","date":"2007","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17336938","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22683820","id":"PMC_22683820","title":"Role of GSTM1 in resistance to lung inflammation.","date":"2012","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22683820","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10102674","id":"PMC_10102674","title":"Immunomodulatory action of class mu-, delta- and kappa-opioid receptor agonists in mice.","date":"1998","source":"Neuropeptides","url":"https://pubmed.ncbi.nlm.nih.gov/10102674","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8589425","id":"PMC_8589425","title":"Infections with various types of organisms stimulate transcription from a short promoter fragment of the potato gst1 gene.","date":"1996","source":"Molecular plant-microbe interactions : MPMI","url":"https://pubmed.ncbi.nlm.nih.gov/8589425","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20853551","id":"PMC_20853551","title":"GSTT1 and GSTM1 gene deletions are not associated with hepatotoxicity caused by antitubercular drugs.","date":"2010","source":"Journal of clinical pharmacy and therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/20853551","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21243008","id":"PMC_21243008","title":"Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: a case-control study in Tehran, Iran.","date":"2011","source":"Prostate cancer and prostatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/21243008","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15173681","id":"PMC_15173681","title":"Mu opiate receptor subtypes.","date":"2004","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/15173681","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14662415","id":"PMC_14662415","title":"GSTM1 polymorphism and oral squamous cell carcinoma.","date":"2004","source":"Oral oncology","url":"https://pubmed.ncbi.nlm.nih.gov/14662415","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15141365","id":"PMC_15141365","title":"GSTM1, GSTT1, and GSTP1 genotypes and the genotoxicity of hydroquinone in human lymphocytes.","date":"2004","source":"Environmental and molecular mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/15141365","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18948376","id":"PMC_18948376","title":"Population-specific GSTM1 copy number variation.","date":"2008","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18948376","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28720685","id":"PMC_28720685","title":"The Loss of GSTM1 Associates with Kidney Failure and Heart Failure.","date":"2017","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/28720685","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22660220","id":"PMC_22660220","title":"Genetic polymorphism of drug metabolizing enzymes (GSTM1 and CYP1A1) as risk factors for oral premalignant lesions and oral cancer.","date":"2012","source":"Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia","url":"https://pubmed.ncbi.nlm.nih.gov/22660220","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21615938","id":"PMC_21615938","title":"Genetic polymorphisms in folate pathway enzymes, DRD4 and GSTM1 are related to temporomandibular disorder.","date":"2011","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21615938","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12944179","id":"PMC_12944179","title":"Interaction between smoking, GSTM1 deletion and colorectal cancer: results from the GSEC study.","date":"2003","source":"Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/12944179","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12716303","id":"PMC_12716303","title":"Polymorphism in GSTM1, GSTT1, and GSTP1 and Susceptibility to Lung Cancer in a Japanese Population.","date":"2000","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/12716303","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11501853","id":"PMC_11501853","title":"Genetic polymorphisms of CYP1A1 and GSTM1 and lung cancer risk.","date":"2001","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/11501853","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11719393","id":"PMC_11719393","title":"Increased frequencies of glutathione S-transferase (GSTM1 and GSTT1) gene deletions in Korean patients with acquired aplastic anemia.","date":"2001","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11719393","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19856098","id":"PMC_19856098","title":"Genetic variants in GSTM3 gene within GSTM4-GSTM2-GSTM1-GSTM5-GSTM3 cluster influence breast cancer susceptibility depending on GSTM1.","date":"2009","source":"Breast cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/19856098","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9007528","id":"PMC_9007528","title":"Expression of mu-, delta- and kappa-opioid receptors in baculovirus-infected insect cells.","date":"1996","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9007528","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7494457","id":"PMC_7494457","title":"Opioid mu- and kappa-receptor mediate phospholipase C activation through Gi1 in Xenopus oocytes.","date":"1995","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/7494457","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6316374","id":"PMC_6316374","title":"Effects of mu- and kappa-opioid receptor agonists on urinary output in mice.","date":"1983","source":"Pharmacology, biochemistry, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/6316374","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16154589","id":"PMC_16154589","title":"Control of bacteriophage mu lysogenic repression.","date":"2005","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16154589","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20036620","id":"PMC_20036620","title":"GSTT1 and GSTM1 null mutations and adverse reactions induced by antituberculosis drugs in Koreans.","date":"2009","source":"Tuberculosis (Edinburgh, Scotland)","url":"https://pubmed.ncbi.nlm.nih.gov/20036620","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11972346","id":"PMC_11972346","title":"Human DNA polymerase mu (Pol mu) exhibits an unusual replication slippage ability at AAF lesion.","date":"2002","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/11972346","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26295386","id":"PMC_26295386","title":"Genetic Polymorphisms of Glutathione-Related Enzymes (GSTM1, GSTT1, and GSTP1) and Schizophrenia Risk: A Meta-Analysis.","date":"2015","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26295386","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11964383","id":"PMC_11964383","title":"The polarized epithelia-specific mu 1B-adaptin complements mu 1A-deficiency in fibroblasts.","date":"2002","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/11964383","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2415657","id":"PMC_2415657","title":"Truncated mu (mu') chains in murine IgM. Evidence that mu' chains lack variable regions.","date":"1985","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/2415657","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11424177","id":"PMC_11424177","title":"Role of glutathione S-transferase mu (GSTM1) in styrene-7,8-oxide toxicity and mutagenicity.","date":"2001","source":"Environmental and molecular mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/11424177","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6450311","id":"PMC_6450311","title":"Transcription of bacteriophage Mu. II. Transcription of the repressor gene.","date":"1980","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/6450311","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6288263","id":"PMC_6288263","title":"DNA intermediates in transposition of phage Mu.","date":"1982","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/6288263","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20504102","id":"PMC_20504102","title":"Association between GSTM1 gene polymorphism in Iranian patients with endometriosis.","date":"2010","source":"Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/20504102","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16475012","id":"PMC_16475012","title":"Activation of the pathogen-inducible Gst1 promoter of potato after elicitation by Venturia inaequalis and Erwinia amylovora in transgenic apple (Malus x domestica).","date":"2006","source":"Transgenic research","url":"https://pubmed.ncbi.nlm.nih.gov/16475012","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30989213","id":"PMC_30989213","title":"Hypomethylation of the GSTM1 promoter is associated with ovarian endometriosis.","date":"2019","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/30989213","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16242731","id":"PMC_16242731","title":"Effects of prenatal cocaine, morphine, or both on postnatal opioid (mu) receptor development.","date":"2005","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/16242731","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1574740","id":"PMC_1574740","title":"Mapping of the human GSPT1 gene, a human homolog of the yeast GST1 gene, to chromosomal band 16p13.1.","date":"1992","source":"Somatic cell and molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1574740","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16938565","id":"PMC_16938565","title":"Relation of glutathione S-transferase genotypes (GSTM1 and GSTT1) to laryngeal squamous cell carcinoma risk.","date":"2006","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/16938565","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35471081","id":"PMC_35471081","title":"Endolysin Regulation in Phage Mu Lysis.","date":"2022","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/35471081","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29765533","id":"PMC_29765533","title":"GSTM1, GSTT1, and GSTP1 polymorphisms and colorectal cancer risk in Polish nonsmokers.","date":"2018","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29765533","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20942828","id":"PMC_20942828","title":"Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer.","date":"2010","source":"BJU international","url":"https://pubmed.ncbi.nlm.nih.gov/20942828","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19838921","id":"PMC_19838921","title":"Dietary isothiocyanates, glutathione S-transferase M1 (GSTM1), and lung cancer risk in African Americans and Caucasians from Los Angeles County, California.","date":"2009","source":"Nutrition and cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19838921","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6958072","id":"PMC_6958072","title":"Gene for glutathione S-transferase-1 (GST1) is on human chromosome 11.","date":"1982","source":"Somatic cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/6958072","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17563610","id":"PMC_17563610","title":"Glutathione S-transferases GSTM1 and GSTT1 polymorphisms and asbestosis.","date":"2007","source":"Journal of occupational and environmental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17563610","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23840148","id":"PMC_23840148","title":"CYP1A1, GSTM1, GSTT1 and NQO1 polymorphisms and colorectal adenomas in Japanese men.","date":"2013","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/23840148","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10513565","id":"PMC_10513565","title":"Antinociceptive properties of FR140423 mediated through spinal delta-, but not mu- and kappa-, opioid receptors.","date":"1999","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10513565","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19634112","id":"PMC_19634112","title":"Effect of polymorphisms in XRCC1, CCND1 and GSTM1 and tobacco exposure as risk modifier for oral leukoplakia.","date":"2009","source":"The International journal of biological markers","url":"https://pubmed.ncbi.nlm.nih.gov/19634112","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10923314","id":"PMC_10923314","title":"[GSTM1 gene polymorphism in patients with head and neck tumors].","date":"2000","source":"Laryngo- rhino- otologie","url":"https://pubmed.ncbi.nlm.nih.gov/10923314","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20957336","id":"PMC_20957336","title":"CYP1A2*1F and GSTM1 alleles are associated with susceptibility to porphyria cutanea tarda.","date":"2010","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/20957336","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19640174","id":"PMC_19640174","title":"Glutathione S-transferase (GSTM1 and GSTT1) polymorphisms in cervical cancer in Northeastern Thailand.","date":"2009","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/19640174","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3864155","id":"PMC_3864155","title":"Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties.","date":"1985","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/3864155","citation_count":1165,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11751440","id":"PMC_11751440","title":"Metabolic gene polymorphism frequencies in control populations.","date":"2001","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/11751440","citation_count":701,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3174634","id":"PMC_3174634","title":"Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion.","date":"1988","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/3174634","citation_count":692,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21565611","id":"PMC_21565611","title":"Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.","date":"2011","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21565611","citation_count":507,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16112301","id":"PMC_16112301","title":"NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.","date":"2005","source":"Lancet (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16112301","citation_count":477,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19498054","id":"PMC_19498054","title":"Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation.","date":"2009","source":"American journal of respiratory and critical care medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19498054","citation_count":451,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8403204","id":"PMC_8403204","title":"Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer.","date":"1993","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/8403204","citation_count":413,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16917939","id":"PMC_16917939","title":"Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism.","date":"2006","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16917939","citation_count":410,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14744259","id":"PMC_14744259","title":"14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking.","date":"2004","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/14744259","citation_count":372,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20972438","id":"PMC_20972438","title":"A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.","date":"2010","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20972438","citation_count":369,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11278289","id":"PMC_11278289","title":"Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11278289","citation_count":324,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12072547","id":"PMC_12072547","title":"Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer.","date":"2002","source":"Journal of the National Cancer Institute","url":"https://pubmed.ncbi.nlm.nih.gov/12072547","citation_count":295,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15213713","id":"PMC_15213713","title":"A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer.","date":"2004","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15213713","citation_count":293,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15714076","id":"PMC_15714076","title":"CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis.","date":"2005","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15714076","citation_count":263,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35063084","id":"PMC_35063084","title":"Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration.","date":"2022","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/35063084","citation_count":256,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19898482","id":"PMC_19898482","title":"Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.","date":"2009","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19898482","citation_count":243,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14726165","id":"PMC_14726165","title":"Effect of glutathione-S-transferase M1 and P1 genotypes on xenobiotic enhancement of allergic responses: randomised, placebo-controlled crossover study.","date":"2004","source":"Lancet (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/14726165","citation_count":239,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12419832","id":"PMC_12419832","title":"A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.","date":"2002","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/12419832","citation_count":236,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10625170","id":"PMC_10625170","title":"Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review.","date":"2000","source":"American journal of epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/10625170","citation_count":230,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17207965","id":"PMC_17207965","title":"hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genes.","date":"2007","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/17207965","citation_count":222,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12186820","id":"PMC_12186820","title":"Effects of glutathione S-transferase M1, maternal smoking during pregnancy, and environmental tobacco smoke on asthma and wheezing in children.","date":"2002","source":"American journal of respiratory and critical care medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12186820","citation_count":218,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17401013","id":"PMC_17401013","title":"Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy.","date":"2007","source":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17401013","citation_count":218,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15113959","id":"PMC_15113959","title":"Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype.","date":"2004","source":"The Journal of nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/15113959","citation_count":213,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12151353","id":"PMC_12151353","title":"Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk.","date":"2002","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/12151353","citation_count":212,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15746160","id":"PMC_15746160","title":"Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer.","date":"2005","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/15746160","citation_count":207,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50647,"output_tokens":2442,"usd":0.094285},"stage2":{"model":"claude-opus-4-6","input_tokens":5744,"output_tokens":2113,"usd":0.122317},"total_usd":0.489387,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":66292,"output_tokens":3112,"usd":0.122778},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6706,"output_tokens":2659,"usd":0.150007}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"GSTM1, GSTM2, GSTM3, GSTM4, and GSTM5 glutathione transferase genes were mapped to human chromosome 1p13.3 using locus-specific PCR primer pairs on human/hamster somatic cell hybrids, confirmed by Southern blot hybridization and fluorescence in situ hybridization with a yeast artificial chromosome clone (GSTM-YAC2) containing all five genes. The close physical proximity of GSTM1 and GSTM2 (sharing 99% nucleotide sequence identity over 460 nucleotides of 3'-UTR) suggests the GSTM1-null allele results from unequal crossing-over.\",\n      \"method\": \"PCR with locus-specific primers on somatic cell hybrids, Southern blot hybridization, FISH with YAC clone\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (PCR, Southern blot, FISH, YAC cloning) in a single study with rigorous controls\",\n      \"pmids\": [\"8317488\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"GSTM1 null genotype results in absence of enzyme activity, and cell lines deficient in GSTM1 were significantly more sensitive to styrene-7,8-oxide (SO)-induced toxicity and mutagenicity (higher mutation frequency at the hprt locus) compared to GSTM1-proficient cell lines, demonstrating that GSTM1 conjugates SO with glutathione and reduces its genotoxic hazard.\",\n      \"method\": \"Cell survival assay (IC50 determination), mutation frequency assay at hprt locus, RT-PCR and immunochemistry for GSTM1 status\",\n      \"journal\": \"Environmental and molecular mutagenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO/deficient cell lines with defined phenotypic readout (toxicity and mutagenicity), single lab\",\n      \"pmids\": [\"11424177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"GSTM1 null genotype (zero enzyme activity) results from homozygous gene deletion; lymphocytes from GSTM1-null individuals showed significantly higher frequencies of micronuclei (but not SCE) induced by hydroquinone compared to GSTM1-present individuals, indicating GSTM1 is involved in the metabolic detoxification of hydroquinone and protects against hydroquinone-induced chromosomal damage.\",\n      \"method\": \"Micronucleus assay and sister chromatid exchange assay in human lymphocytes stratified by GSTM1 genotype\",\n      \"journal\": \"Environmental and molecular mutagenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genotype-stratified human primary cell experiment with defined genotoxic endpoint, single lab\",\n      \"pmids\": [\"15141365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"GSTM1-null genotype was associated with higher placental DNA adduct levels compared to GSTM1-positive genotype, particularly in environmentally polluted regions and in non-smokers, demonstrating that GSTM1 enzymatic activity reduces bulky PAH-DNA adduct formation in vivo.\",\n      \"method\": \"32P-postlabeling DNA adduct analysis in human placenta combined with PCR-based GSTM1 genotyping\",\n      \"journal\": \"Environmental and molecular mutagenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genotype-stratified human biomonitoring with direct molecular endpoint (DNA adducts), replicated across two studies (PMIDs 9329643 and 9150753)\",\n      \"pmids\": [\"9329643\", \"9150753\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"A functional polymorphism in the GSTM1 promoter region alters binding of the AP-2alpha transcription factor, resulting in reduced promoter activity and mRNA expression. Homozygous GSTM1 null (-/-) and homozygous wild-type (+/+) both associate with increased breast cancer risk compared to heterozygotes (+/-), suggesting a U-shaped (non-linear) gene-dosage relationship for GSTM1 enzymatic activity in breast cancer protection.\",\n      \"method\": \"Case-control genotyping distinguishing null/heterozygous/homozygous wild-type; promoter activity reporter assays; electrophoretic mobility shift assay for AP-2alpha binding; meta-analysis\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — promoter functional assay plus EMSA identifying a transcriptional mechanism, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"19228880\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The GSTM1 promoter region is significantly hypomethylated in ectopic and eutopic endometrium of patients with ovarian endometriosis, negatively correlating with elevated GSTM1 mRNA and protein expression. In vitro overexpression of GSTM1 in endometrial epithelial cells increased viability and inhibited apoptosis following hormone treatment and withdrawal, indicating GSTM1 negatively regulates apoptosis in endometrial cells.\",\n      \"method\": \"Pyrosequencing of promoter methylation, RT-qPCR and IHC for expression, gene transfection with cell viability (CCK-8) and flow cytometry apoptosis assays\",\n      \"journal\": \"Human reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods linking promoter methylation to expression and functional apoptosis phenotype, single lab\",\n      \"pmids\": [\"30989213\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"GSTM1 acts in lung inflammation resistance through interactions with other genes and environmental factors (especially air pollutants), with the null polymorphism associated with increased susceptibility to oxidative stress-related lung diseases. GSTM1 expression is regulated by the NF-E2-related factor 2 (Nrf2) transcription factor.\",\n      \"method\": \"Review synthesizing epidemiological, clinical, animal, and in vitro studies; Nrf2 regulation established by gene expression studies\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — review-based synthesis without new primary experimental data; mechanistic claims supported indirectly\",\n      \"pmids\": [\"22683820\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Population-specific copy number variation (CNV) exists at the GSTM1 locus: more than 75% of Caucasian (CEU) samples exhibit GSTM1 deletion and none contain two copies, while up to 25% of African (YRI) samples carry two copies of GSTM1. A HapMap pseudo-SNP (rs366631) arising from sequence homology can serve as a marker of GSTM1 gene deletion.\",\n      \"method\": \"Site-specific genotyping assays, CNV assays (qPCR-based) for three GSTM1 regions in HapMap CEU and YRI lymphoblastoid cell lines\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — novel CNV assay with multiple genomic regions tested across two populations, clear mechanistic finding about gene dosage\",\n      \"pmids\": [\"18948376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1985,\n      \"finding\": \"GSTM1 (GST1 locus) is not expressed in most fetal tissues before 30 weeks of gestation but steadily increases thereafter until adult levels are reached in late infancy, demonstrating a developmental regulation of GSTM1 expression that is tissue-specific.\",\n      \"method\": \"Starch gel electrophoresis and chromatofocusing of GST isoenzymes in fetal, neonatal, and infant tissues\",\n      \"journal\": \"Biochemical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct protein-level detection across developmental stages with tissue specificity, single lab\",\n      \"pmids\": [\"4084207\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GSTM1 encodes a class-mu glutathione S-transferase enzyme that catalyzes the conjugation of glutathione with electrophilic compounds including PAH metabolites, styrene oxide, hydroquinone, and isothiocyanates, thereby detoxifying carcinogens and reducing DNA adduct formation; the gene resides in a cluster (GSTM1–GSTM5) on chromosome 1p13.3, is subject to common homozygous deletion (null allele arising from unequal crossing-over) and copy number variation that is population-specific, is transcriptionally regulated by Nrf2 and by promoter methylation/AP-2alpha binding, and additionally functions through protein–protein interactions to negatively regulate apoptosis signaling in certain cell types.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1985,\n      \"finding\": \"GSTM1 (class-mu glutathione transferase) was identified as a distinct enzyme class based on amino-terminal amino acid sequences, substrate specificities, inhibitor sensitivities, and immunological cross-reactivity, establishing the alpha, mu, and pi classification of cytosolic glutathione transferases across rat, mouse, and human species.\",\n      \"method\": \"Amino-terminal sequencing, substrate specificity assays, inhibitor sensitivity panels, immunoprecipitation with class-specific antibodies, pattern recognition analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multi-method biochemical characterization across species, foundational classification paper with >1000 citations\",\n      \"pmids\": [\"3864155\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"The GSTM1-null phenotype (absence of class-mu glutathione transferase activity on trans-stilbene oxide) results from a gene deletion: individuals lacking enzyme activity also lack class-mu GT mRNA and a corresponding genomic restriction fragment, demonstrating that homozygous gene deletion abolishes GSTM1 expression.\",\n      \"method\": \"Northern blotting for mRNA levels, Southern blotting of genomic DNA with class-mu cDNA probe, enzyme activity assays in peripheral leukocytes\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution of genotype-phenotype link with mRNA, genomic DNA, and enzymatic activity, >600 citations\",\n      \"pmids\": [\"3174634\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"GSTM1, GSTM2, GSTM3, GSTM4, and GSTM5 were mapped to human chromosome 1p13.3 as a tandem gene cluster spanning ~100 kb; the close physical proximity of GSTM1 and GSTM2 (99% nucleotide sequence identity in 3'-UTR) suggests the GSTM1-null allele arises from unequal crossing-over.\",\n      \"method\": \"Locus-specific PCR on human/hamster somatic cell hybrid DNAs, Southern blot hybridization, fluorescence in situ hybridization (FISH) with a yeast artificial chromosome clone containing all five genes\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal mapping methods, replicated across somatic cell hybrids and FISH\",\n      \"pmids\": [\"8317488\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Mouse GSTM1-1 (mGSTM1-1) physically interacts with apoptosis signal-regulating kinase 1 (ASK1), suppresses ASK1 kinase activity and oligomerization, and inhibits ASK1-dependent apoptosis; binding requires the C-terminal portion of mGSTM1-1 and the N-terminal region of ASK1, and this inhibitory function is independent of GSTM1's glutathione-conjugating catalytic activity.\",\n      \"method\": \"Yeast two-hybrid screen for ASK1-interacting proteins; co-immunoprecipitation in vivo and in vitro binding assay confirming direct interaction; domain-mapping with deletion constructs; kinase activity assay in cultured cells; ASK1 oligomerization assay; apoptosis assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — yeast two-hybrid plus reciprocal Co-IP plus in vitro binding plus functional kinase/apoptosis assays, >300 citations\",\n      \"pmids\": [\"11278289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Human cell lines expressing functional GSTM1 are significantly more resistant to styrene-7,8-oxide (SO)-induced cytotoxicity and mutagenicity at the HPRT locus than GSTM1-null cell lines, directly demonstrating that GSTM1 enzymatic activity conjugates SO and reduces its genotoxic hazard.\",\n      \"method\": \"RT-PCR and immunochemistry for GSTM1 status in human cell lines; dose-response cytotoxicity assay; HPRT mutation frequency assay with 6-thioguanine selection\",\n      \"journal\": \"Environmental and molecular mutagenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal cell-based assays in isogenic GSTM1-present vs. null lines, single study\",\n      \"pmids\": [\"11424177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"GSTM1 null genotype (loss of GSTM1 enzyme activity) results in significantly higher micronucleus frequency in human lymphocytes treated with hydroquinone compared to GSTM1-present individuals, establishing GSTM1's role in detoxifying hydroquinone and protecting against genotoxic DNA damage.\",\n      \"method\": \"GSTM1 genotyping of 15 healthy donors; ex vivo lymphocyte culture treatment with hydroquinone; cytokinesis-block micronucleus assay; sister-chromatid exchange assay\",\n      \"journal\": \"Environmental and molecular mutagenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct functional comparison in human cells stratified by GSTM1 genotype, single study\",\n      \"pmids\": [\"15141365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"GSTM1 null genotype modifies the adjuvant effect of diesel exhaust particles on nasal allergic responses: GSTM1-null individuals show significantly greater IgE and histamine increases after diesel exhaust particle plus allergen challenge compared to GSTM1-functional individuals, indicating GSTM1's role in metabolizing reactive oxygen species generated by diesel exhaust particles.\",\n      \"method\": \"Randomised, placebo-controlled crossover nasal challenge study; intranasal allergen ± diesel exhaust particle challenge; nasal lavage measurement of IgE, histamine, IL-4, IFN-γ; GSTM1/GSTP1 genotyping\",\n      \"journal\": \"Lancet (London, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — randomised controlled crossover design with direct functional genotype-phenotype comparison, >200 citations\",\n      \"pmids\": [\"14726165\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"A functional polymorphism in the GSTM1 promoter alters AP-2α transcription factor binding, reducing promoter activity and mRNA expression; notably, both the null (-/-) and homozygous wild-type (+/+) genotypes confer breast cancer risk relative to heterozygotes (+/-), revealing a U-shaped gene-dosage association and indicating that GSTM1 expression level critically determines its protective or detrimental role.\",\n      \"method\": \"Case-control genotyping (1920 subjects) with distinction of null/heterozygous/homozygous genotypes; meta-analysis of 41 studies; electrophoretic mobility shift assay (EMSA) for AP-2α binding to promoter variant; luciferase reporter promoter activity assay; quantitative RT-PCR for mRNA expression\",\n      \"journal\": \"FASEB journal : official publication of the Federation of American Societies for Experimental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — EMSA plus reporter assay plus mRNA quantification establishing functional promoter mechanism, replicated in meta-analysis\",\n      \"pmids\": [\"19228880\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"GSTM1 functions as an antioxidant enzyme regulated by the NRF2 (NF-E2-related factor 2) transcription factor pathway and acts through interactions with other genes and environmental factors (particularly air pollutants) to modulate lung inflammatory responses; GSTM1-null individuals show increased susceptibility to oxidant-driven pulmonary inflammation.\",\n      \"method\": \"Review synthesizing epidemiological, clinical, animal model, and in vitro studies; evidence from GSTM1 knockout/knockdown experiments and NRF2 pathway analyses\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — review integrating multiple experimental systems; primary mechanistic evidence from cited in vitro/animal studies\",\n      \"pmids\": [\"22683820\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Hypomethylation of the GSTM1 promoter in ectopic and eutopic endometrium of patients with ovarian endometriosis correlates with higher GSTM1 mRNA and protein expression; in vitro overexpression of GSTM1 in endometrial epithelial cells increases cell viability and inhibits apoptosis following hormone treatment and withdrawal, consistent with GSTM1's known role in suppressing apoptosis-related signalling (e.g., ASK1).\",\n      \"method\": \"Pyrosequencing of GSTM1 promoter CpG methylation; RT-qPCR and immunohistochemistry for GSTM1 expression; primary endometrial epithelial cell culture; GSTM1 overexpression by gene transfection; CCK-8 viability assay; flow cytometry for apoptosis\",\n      \"journal\": \"Human reproduction (Oxford, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods linking promoter methylation to expression and functional apoptosis phenotype, single study\",\n      \"pmids\": [\"30989213\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Population-specific copy number variation (CNV) of GSTM1 was identified: >75% of Caucasian (CEU) samples carry GSTM1 deletion and none have two copies, whereas up to 25% of African (YRI) samples carry two copies; an upstream deletion marker (pseudo-SNP rs366631 on HapMap) serves as an indicator of full GSTM1 gene deletion.\",\n      \"method\": \"Site-specific genotyping assays for GSTM1 and a homologous upstream region; novel GSTM1 CNV assay applied to HapMap CEU and YRI lymphoblastoid cell lines; genome-wide association analysis identifying false SNP call due to sequence homology\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — novel CNV assay with population-specific validation, single study\",\n      \"pmids\": [\"18948376\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GSTM1 encodes a class-mu cytosolic glutathione S-transferase whose primary catalytic function is conjugation of electrophilic compounds (including carcinogens such as styrene oxide and hydroquinone, and reactive oxygen species from pollutants) with glutathione to facilitate their detoxification; independently of its catalytic activity, GSTM1 protein directly binds and inhibits apoptosis signal-regulating kinase 1 (ASK1) by suppressing its oligomerization and kinase activity, thereby modulating stress-induced apoptosis; GSTM1 expression is regulated at the promoter level by AP-2α binding and by DNA methylation, and the common null allele (arising from homozygous gene deletion via unequal crossing-over at the chromosome 1p13.3 cluster) completely abolishes both enzymatic and ASK1-inhibitory functions, predisposing null individuals to increased genotoxic damage and inflammatory responses.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GSTM1 encodes a class-mu glutathione S-transferase that catalyzes the conjugation of glutathione to electrophilic substrates including styrene oxide, hydroquinone, and polycyclic aromatic hydrocarbon (PAH) metabolites, thereby detoxifying environmental carcinogens and reducing genotoxic DNA adduct formation [PMID:11424177, PMID:15141365, PMID:9329643]. The gene resides in a five-gene cluster (GSTM1–GSTM5) at chromosome 1p13.3, and a common homozygous deletion (null allele), arising from unequal crossing-over between highly homologous GSTM1 and GSTM2 sequences, abolishes enzyme activity and exhibits marked population-specific copy number variation [PMID:8317488, PMID:18948376]. Transcription is regulated by Nrf2 and by AP-2alpha binding at a functional promoter polymorphism, and promoter methylation status modulates expression levels in specific tissues [PMID:19228880, PMID:30989213]. Beyond xenobiotic detoxification, GSTM1 overexpression in endometrial epithelial cells increases viability and inhibits apoptosis, indicating an additional role in regulating programmed cell death [PMID:30989213].\",\n  \"teleology\": [\n    {\n      \"year\": 1985,\n      \"claim\": \"Establishing that GSTM1 expression is developmentally regulated answered when the enzyme becomes available for xenobiotic detoxification and showed that fetal tissues lack this protective activity until late gestation.\",\n      \"evidence\": \"Starch gel electrophoresis and chromatofocusing of GST isoenzymes in human fetal, neonatal, and infant tissues\",\n      \"pmids\": [\"4084207\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Transcriptional versus post-transcriptional basis of developmental onset not determined\", \"Tissue-specific regulatory elements not identified\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Mapping all five GSTM genes to a single cluster at 1p13.3 and documenting near-identical 3′-UTR sequences between GSTM1 and GSTM2 provided the mechanistic basis for the common null allele via unequal crossing-over.\",\n      \"evidence\": \"Locus-specific PCR on somatic cell hybrids, Southern blot, FISH with a YAC clone spanning the cluster\",\n      \"pmids\": [\"8317488\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Exact breakpoints of the deletion allele not characterized at nucleotide resolution\", \"Frequency of de novo deletion events unknown\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstrating that GSTM1-null individuals accumulate higher levels of bulky PAH-DNA adducts in placental tissue established an in vivo detoxification role for GSTM1 against environmental carcinogens.\",\n      \"evidence\": \"32P-postlabeling DNA adduct analysis in human placenta stratified by PCR-based GSTM1 genotype\",\n      \"pmids\": [\"9329643\", \"9150753\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Contribution of other GST isoforms to residual adduct clearance not quantified\", \"Adduct types not fully speciated\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Showing that GSTM1-deficient cell lines are more sensitive to styrene oxide-induced cytotoxicity and mutagenicity directly linked GSTM1 catalytic activity to glutathione conjugation of this specific electrophile.\",\n      \"evidence\": \"IC50 and hprt mutation frequency assays in GSTM1-proficient versus -deficient human cell lines\",\n      \"pmids\": [\"11424177\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Kinetic parameters (Km, Vmax) for styrene oxide conjugation by purified GSTM1 not reported\", \"Rescue by GSTM1 re-expression not performed\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Genotype-stratified micronucleus assays in human lymphocytes extended the substrate repertoire to hydroquinone, showing GSTM1 protects against hydroquinone-induced chromosomal damage.\",\n      \"evidence\": \"Micronucleus and sister chromatid exchange assays in lymphocytes from GSTM1-null versus -positive donors\",\n      \"pmids\": [\"15141365\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct enzymatic conjugation of hydroquinone by purified GSTM1 not demonstrated\", \"Confounding by other polymorphic detoxification enzymes not fully controlled\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Quantifying population-specific copy number variation at the GSTM1 locus revealed that gene dosage varies continuously (0, 1, or 2 copies), moving beyond the binary null/present model and explaining inter-population differences in detoxification capacity.\",\n      \"evidence\": \"qPCR-based CNV assays across three GSTM1 regions in HapMap CEU and YRI lymphoblastoid cell lines\",\n      \"pmids\": [\"18948376\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional impact of two copies versus one copy on enzyme activity not measured directly\", \"CNV frequencies in additional populations not assessed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identifying a functional promoter polymorphism that alters AP-2alpha binding and reduces GSTM1 transcription provided a second axis of expression regulation beyond gene deletion, revealing that even among non-null carriers, transcriptional variation modulates cancer risk.\",\n      \"evidence\": \"Luciferase reporter assays, EMSA for AP-2alpha binding, case-control genotyping in breast cancer cohort\",\n      \"pmids\": [\"19228880\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Chromatin context of AP-2alpha regulation not examined\", \"U-shaped risk curve mechanism not mechanistically explained\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Linking promoter hypomethylation to elevated GSTM1 expression and demonstrating that GSTM1 overexpression inhibits apoptosis in endometrial cells expanded the gene's function beyond xenobiotic metabolism to a role in cell survival regulation.\",\n      \"evidence\": \"Pyrosequencing, RT-qPCR, IHC in endometriosis samples; GSTM1 overexpression with CCK-8 viability and flow cytometry apoptosis assays in vitro\",\n      \"pmids\": [\"30989213\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Protein interaction partners mediating anti-apoptotic signaling not identified\", \"Generalizability of anti-apoptotic function to other cell types not tested\", \"Mechanism linking GST catalytic activity to apoptosis suppression unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The molecular mechanism by which GSTM1 inhibits apoptosis — whether through catalytic detoxification of pro-apoptotic lipid peroxidation products, direct protein–protein interactions with apoptotic regulators, or another route — remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No interacting partners in apoptosis pathway identified\", \"Structure–function relationship between GST catalytic site and anti-apoptotic activity not dissected\", \"In vivo validation of anti-apoptotic role lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [1, 2, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [1, 2, 3]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"NRF2\",\n      \"TFAP2A\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"GSTM1 is a class-mu cytosolic glutathione S-transferase that conjugates electrophilic substrates—including carcinogens such as styrene oxide and hydroquinone, and reactive oxygen species derived from pollutants—with glutathione, thereby protecting cells from genotoxic damage and oxidant-driven inflammation [PMID:3864155, PMID:11424177, PMID:15141365, PMID:14726165]. Independent of its catalytic activity, GSTM1 directly binds apoptosis signal-regulating kinase 1 (ASK1) through its C-terminal domain, suppressing ASK1 oligomerization and kinase activity to inhibit stress-induced apoptosis [PMID:11278289, PMID:30989213]. The common GSTM1-null allele, generated by homozygous deletion via unequal crossing-over within the tandem gene cluster at chromosome 1p13.3, eliminates both enzymatic and ASK1-inhibitory functions; GSTM1 transcription is further modulated by AP-2α binding at a functional promoter polymorphism and by promoter CpG methylation [PMID:3174634, PMID:8317488, PMID:19228880, PMID:30989213]. GSTM1-null individuals exhibit heightened susceptibility to pollutant-augmented allergic inflammation and increased genotoxic damage, consistent with loss of both detoxification and anti-apoptotic protective mechanisms [PMID:14726165, PMID:15141365].\",\n  \"teleology\": [\n    {\n      \"year\": 1985,\n      \"claim\": \"Identification of GSTM1 as a distinct enzyme class (mu) among cytosolic glutathione transferases established the foundational biochemical classification and substrate specificity framework for the gene family.\",\n      \"evidence\": \"Amino-terminal sequencing, substrate specificity profiling, inhibitor sensitivity panels, and immunoprecipitation across rat, mouse, and human tissues\",\n      \"pmids\": [\"3864155\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Catalytic mechanism at the active-site level not resolved\", \"No structural model available at this point\", \"Human isoform-specific functions not distinguished\"]\n    },\n    {\n      \"year\": 1988,\n      \"claim\": \"Demonstration that the GSTM1-null phenotype arises from a homozygous gene deletion—abolishing mRNA expression and enzyme activity—explained the polymorphic absence of mu-class GST activity in human populations and established the null genotype as a binary loss-of-function variant.\",\n      \"evidence\": \"Northern blotting, Southern blotting with class-mu cDNA probe, and enzyme activity assays in peripheral leukocytes\",\n      \"pmids\": [\"3174634\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise molecular breakpoints of the deletion not mapped\", \"Functional consequences beyond trans-stilbene oxide metabolism not yet tested\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Mapping all five GSTM genes to a tandem cluster at 1p13.3 and identifying near-identical 3′-UTR sequences between GSTM1 and GSTM2 provided a mechanistic explanation for null-allele generation through unequal crossing-over.\",\n      \"evidence\": \"Locus-specific PCR on somatic cell hybrids, Southern blot hybridization, and FISH with a YAC clone containing the full cluster\",\n      \"pmids\": [\"8317488\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Exact recombination breakpoints not sequenced\", \"Frequency of de novo deletion events unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Discovery that GSTM1 physically binds and inhibits ASK1—suppressing its oligomerization, kinase activity, and downstream apoptosis independently of glutathione conjugation—revealed a catalysis-independent signalling function for GSTM1.\",\n      \"evidence\": \"Yeast two-hybrid screen, reciprocal co-immunoprecipitation, in vitro binding assay, domain-deletion mapping, kinase activity assay, and apoptosis assay in cultured cells (mouse GSTM1)\",\n      \"pmids\": [\"11278289\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the GSTM1–ASK1 interface not determined\", \"Relevance of ASK1 inhibition in human tissues under physiological conditions not tested\", \"Whether other GST-mu family members share ASK1-inhibitory activity unclear\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Functional demonstration that GSTM1-positive human cells resist styrene oxide–induced cytotoxicity and mutagenicity directly linked GSTM1 enzymatic activity to protection against an occupational carcinogen.\",\n      \"evidence\": \"Dose-response cytotoxicity and HPRT mutation frequency assays in isogenic GSTM1-present versus GSTM1-null human cell lines\",\n      \"pmids\": [\"11424177\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single study; replication in additional cell types needed\", \"In vivo dosimetry not established\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Evidence that GSTM1-null individuals show augmented allergic inflammation (higher IgE, histamine) upon diesel exhaust particle challenge, and greater hydroquinone-induced genotoxic damage, extended GSTM1's protective role from chemical carcinogen metabolism to pollutant-driven immune modulation and environmental genotoxicity.\",\n      \"evidence\": \"Randomised crossover nasal challenge study with diesel exhaust particles (human); ex vivo micronucleus assay in GSTM1-genotyped human lymphocytes treated with hydroquinone\",\n      \"pmids\": [\"14726165\", \"15141365\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream mediators linking GSTM1-null status to enhanced IgE production not identified\", \"Whether GSTM1 directly detoxifies diesel exhaust particle-derived ROS or acts indirectly not resolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Characterization of population-specific GSTM1 copy number variation showed that >75% of Caucasians carry the deletion while African populations retain higher copy numbers, highlighting the need to account for CNV rather than simple SNP-based genotyping in association studies.\",\n      \"evidence\": \"Novel CNV genotyping assay applied to HapMap CEU and YRI lymphoblastoid cell lines\",\n      \"pmids\": [\"18948376\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional impact of carrying two versus one copy not directly measured\", \"Broader global population survey of CNV not performed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identification of a functional promoter polymorphism that alters AP-2α transcription factor binding, reducing GSTM1 transcription and revealing a U-shaped gene-dosage effect on breast cancer risk, established that GSTM1 expression level—not just presence versus absence—is a critical determinant of its biological impact.\",\n      \"evidence\": \"Case-control genotyping (1920 subjects), meta-analysis of 41 studies, EMSA for AP-2α binding, luciferase reporter assay, and quantitative RT-PCR\",\n      \"pmids\": [\"19228880\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism underlying the detrimental effect of very high GSTM1 expression not elucidated\", \"Other transcription factors regulating GSTM1 beyond AP-2α and NRF2 not comprehensively surveyed\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Linking GSTM1 promoter hypomethylation to elevated expression in endometriosis, and showing that GSTM1 overexpression increases cell viability and suppresses apoptosis in endometrial epithelial cells, connected the ASK1-inhibitory function to a disease-relevant phenotype and identified epigenetic regulation as a physiological control mechanism.\",\n      \"evidence\": \"Pyrosequencing of promoter CpG methylation, RT-qPCR, immunohistochemistry, GSTM1 overexpression in primary endometrial cells, CCK-8 viability assay, and flow cytometry for apoptosis\",\n      \"pmids\": [\"30989213\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal relationship between GSTM1 overexpression and endometriosis pathogenesis not established\", \"Whether anti-apoptotic effect is mediated via ASK1 in this context not directly tested\", \"No in vivo model used\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis of the GSTM1–ASK1 interaction, the precise mechanism by which high GSTM1 expression becomes detrimental, and the relative contributions of catalytic versus non-catalytic functions in specific disease contexts remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No co-crystal or cryo-EM structure of the GSTM1–ASK1 complex\", \"Quantitative contribution of catalytic detoxification versus ASK1 inhibition to cancer or inflammatory protection not separated in vivo\", \"Comprehensive identification of additional non-catalytic binding partners not performed\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 4, 5]},\n      {\"term_id\": \"GO:0016209\", \"supporting_discovery_ids\": [6, 8]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 4, 5]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [3, 9]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"R-HSA-9748784\", \"supporting_discovery_ids\": [4, 5, 6]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"MAP3K5\"],\n    \"other_free_text\": []\n  }\n}\n```"}